# Spexin and Phoenixin-20 in Girls With Central Precocious Puberty

> **NCT07359092** · — · COMPLETED · sponsor: **Kayseri City Hospital** · enrollment: 143 (actual)

## Conditions studied

- Central Precocious Puberty (CPP)
- Puberty Disorders
- Puberty
- Hypothalamic-Pituitary-Ovarian Axis Dysfunction (Disorder)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07359092
- **Lead sponsor:** Kayseri City Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 143 (ACTUAL)
- **Last updated:** 2026-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07359092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07359092, "Spexin and Phoenixin-20 in Girls With Central Precocious Puberty". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07359092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*